Development and Characterization of Clobetasol Propionate-Loaded Hydrogel for Psoriasis Management

Authors

  • Neelam Rama Sita Devi , Praveen Gujjula, Dr. D Raghava, Dr. Kavala Nageswara Rao Author

DOI:

https://doi.org/10.48047/

Keywords:

Psoriasis, Clobetasol Propionate, Hydrogel, Topical drug delivery, Controlled release

Abstract

Psoriasis is a chronic inflammatory skin condition characterized by hyperproliferation of keratinocytes and immune dysregulation. Topical corticosteroids remain the first-line treatment, with Clobetasol Propionate being one of the most potent.

Downloads

Download data is not yet available.

References

Verma, A. (2013). Formulation and evaluation of clobetasol propionate gel. Asian Journal of Pharmaceutical and Clinical Research, 6(9), 15–18.

Yadav, M., Aggarwal, P., Yadav, D., & Singh, A. (2022). Formulation and evaluation of clobetasol-17-propionate-loaded carboxymethyl chitosan nanoparticle. Asian Journal of Pharmaceutical and Clinical Research, 15(9), 88–93

Downloads

Published

2025-10-07

How to Cite

Neelam Rama Sita Devi , Praveen Gujjula, Dr. D Raghava, Dr. Kavala Nageswara Rao. (2025). Development and Characterization of Clobetasol Propionate-Loaded Hydrogel for Psoriasis Management . History of Medicine, 11(2), 67-73. https://doi.org/10.48047/